Pyxis Oncology Inc. (NASDAQ: PYXS) on Thursday released preliminary data from its ongoing Phase 1 studies of micvotabart pelidotin (MICVO) for recurrent/metastatic head and neck squamous cell ...

The following slide deck was published by Pyxis Oncology, Inc. in conjunction with this event.

Union leaders accuse hospital administrators at the 12 hospitals of trying to cut staff, wages and health care benefits for nurses. “Our bosses are trying to reverse our gains for patient care,” Nancy ...

Ladies and gentlemen, thank you for standing by. Welcome to Pyxis Oncology MICVO Clinical Update Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now ...

Jesse Calis spent a month with the Blackmagic PYXIS 12K cinema camera. His verdict: “If you are a serious filmmaker… this camera is really for you.” And how. Watch his full review of the Blackmagic ...

Pyxis Oncology (PYXS) announced preliminary data from its ongoing Phase 1 clinical studies evaluating micvotabart pelidotin, a first-in-concept antibody-drug conjugate targeting extradomain-B of ...

RBC Capital analyst Leonid Timashev lowered the firm’s price target on Pyxis Oncology (PYXS) to $5 from $8 and keeps an Outperform rating on the shares. The company reported phase 1 data from their ...

Pyxis secured S$13 million in the first close of its S$18 million growth funding round, reflecting strong investor confidence in its vessel technology, commercial traction, and regional growth ...

Shares of Pyxis Oncology dropped after the pharmaceutical company said data from its trials on a treatment for a form of head and neck cancer showed a high incidence of adverse effects. The stock fell ...

本期推荐一款名为Pyxis的跨平台软件，其致力于解决离子淌度质谱成像（IM-MSI）数据处理中因缺乏全流程分析工具而阻碍技术应用的瓶颈问题。研究团队通过开发集成预处理、可视化、数据挖掘与代谢物鉴定功能的计算平台，成功实现对小鼠肾脏组织和THP-1单细胞 ...